Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | 71,900 | reported | 11 Feb 2026 | tx 38+3,167,058−355,529 |
| Trevi Therapeutics, Inc. | 35,000 | reported | 03 Jun 2026 | tx 21+594,938−2,570,218 |
| Kardigan, Inc. | 20,706 | reported | 17 Jun 2026 | tx 1+20,706 |
| SAVIENT PHARMACEUTICALS INC | 16,415 | reported | 07 Jan 2013 | tx 2+12,644−16,415 |
| MyoKardia Inc | 0 | reported | 17 Nov 2020 | tx 17+64,600−60,000 |
| PENWEST PHARMACEUTICALS CO | 0 | reported | 20 Sept 2010 | tx 11+65,970−50,358 |
| GENZYME CORP | 0 | reported | 04 Apr 2011 | tx 44+250,731−557,591 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2026 | GRANT_AWARD | Kardigan, Inc. | 20,706 | 0.00 USD | |
| 03 Jun 2026 | GRANT_AWARD | Trevi Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 11 Feb 2026 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 71,900 | 0.00 USD | deriv |
| 11 Feb 2026 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 107,850 | 0.00 USD | deriv |
| 01 Feb 2026 | TAX_WITHHOLDING | RHYTHM PHARMACEUTICALS, INC. | 31,522 | 108.99 USD | |
| 01 Feb 2026 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 68,713 | — | |
| 01 Feb 2026 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 21,250 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 33,338 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 14,125 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 03 Jun 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 43,620 | 4.59 USD | |
| 03 Jun 2025 | SALE | RHYTHM PHARMACEUTICALS, INC. | 43,346 | 65.04 USD | |
| 03 Jun 2025 | SALE | RHYTHM PHARMACEUTICALS, INC. | 274 | 65.60 USD | |
| 03 Jun 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 43,620 | 0.00 USD | deriv |
| 19 Feb 2025 | SALE | RHYTHM PHARMACEUTICALS, INC. | 9,896 | 57.22 USD | |
| 16 Feb 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 21,250 | — | |
| 14 Feb 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 133,350 | 0.00 USD | deriv |
| 16 Feb 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 21,250 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 200,000 | 0.00 USD | deriv |
| 04 Feb 2025 | SALE | RHYTHM PHARMACEUTICALS, INC. | 4,278 | 59.43 USD | |
| 01 Feb 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 14,125 | — | |
| 01 Feb 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 14,125 | 0.00 USD | deriv |
| 27 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 4,555 | 1.43 USD | |
| 27 Aug 2024 | SALE | Trevi Therapeutics, Inc. | 4,555 | 2.93 USD | |
| 27 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 4,555 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 30 Mar 2021.